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ABSTRACT
OBJECTIVES
To use the estimates from the Global Burden of 
Disease Study 2016 to describe patterns of suicide 
mortality globally, regionally, and for 195 countries 
and territories by age, sex, and Socio-demographic 
index, and to describe temporal trends between 1990 
and 2016.
DESIGN
Systematic analysis.
MAIN OUTCOME MEASURES
Crude and age standardised rates from suicide 
mortality and years of life lost were compared across 
regions and countries, and by age, sex, and Socio-
demographic index (a composite measure of fertility, 
income, and education).
RESULTS
The total number of deaths from suicide increased 
by 6.7% (95% uncertainty interval 0.4% to 15.6%) 
globally over the 27 year study period to 817 000 
(762 000 to 884 000) deaths in 2016. However, the 
age standardised mortality rate for suicide decreased 
by 32.7% (27.2% to 36.6%) worldwide between 1990 
and 2016, similar to the decline in the global age 
standardised mortality rate of 30.6%. Suicide was the 
leading cause of age standardised years of life lost in 
the Global Burden of Disease region of high income 
Asia Pacific and was among the top 10 leading causes 
in eastern Europe, central Europe, western Europe, 
central Asia, Australasia, southern Latin America, and 
high income North America. Rates for men were higher 
than for women across regions, countries, and age 
groups, except for the 15 to 19 age group. There was 
variation in the female to male ratio, with higher ratios 
at lower levels of Socio-demographic index. Women 
experienced greater decreases in mortality rates 
(49.0%, 95% uncertainty interval 42.6% to 54.6%) 
than men (23.8%, 15.6% to 32.7%).
CONCLUSIONS
Age standardised mortality rates for suicide have 
greatly reduced since 1990, but suicide remains an 
important contributor to mortality worldwide. Suicide 
mortality was variable across locations, between 
sexes, and between age groups. Suicide prevention 
strategies can be targeted towards vulnerable 
populations if they are informed by variations in 
mortality rates.
Introduction
Suicide is recognised as a critical public health issue 
by the World Health Organization in its Comprehensive 
Mental Health Action Plan.1 The plan contains a target 
to decrease global suicide mortality by 10% between 
2012 and 2020. Proposed actions for WHO Member 
States include the development and implementation 
of comprehensive national suicide prevention 
strategies, with a focus on populations identified as 
at increased risk for suicide. As of January 2018, 28 
of 194 WHO Member States report having a national 
suicide prevention strategy.2 Suicide mortality is also 
an indicator for Sustainable Development Goal 3.4.2, 
to be used to measure progress towards a targeted 
one third reduction in premature mortality from non-
communicable diseases through enhanced prevention, 
treatment, and promotion of mental health and well 
being.3
Suicide is defined as a death caused by intentional 
self directed injury.4 It varies systematically by age, 
sex, and means of suicide.5 6 A complex web of factors 
underlies suicide mortality, including both risk factors 
and protective factors at individual, family, community, 
and societal levels 7-10; choices of and access to means 
of suicide 11-13; and mental illness and access to mental 
healthcare and other services.14-17 These drivers of 
suicide mortality also vary systematically by region. 
For example, in most parts of the world, suicide deaths 
are higher among men than women,5 although this 
ratio is much lower for countries across a belt that 
extends from southern India to China, including some 
islands in the Pacific ocean.5 18 19 In Western countries, 
there is a strong relation between mental illness and 
suicide,20 however, in Asia, this relation is much less 
pronounced.21
Given the focus on preventing suicide internationally 
and by specific countries, an accounting of levels 
and trends of suicide mortality, including analyses 
by region, country, age, and sex is necessary to 
inform suicide prevention efforts. However, suicide 
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is stigmatised and, in some countries, illegal, which 
can lead to misclassification and variability in data 
quality.5 22 The methods of the Global Burden of 
Disease Study 2016,23 which address some of this 
misclassification through data processing, provide 
an opportunity to present internationally comparable 
estimates of suicide that account for some of these data 
issues. Details on how misclassification is handled are 
outlined in the Global Burden of Disease Study 2016 
Causes of Death appendix.23
The standardised methods and comprehensive data 
of the Global Burden of Disease Study 2016 facilitate an 
assessment of the patterns of suicide mortality in 2016 
by age, sex, and location, and allow comparisons across 
the period of 1990 to 2016. The data and methods in 
the Global Burden of Disease Study 2016 represent 
substantive improvements to previous iterations of the 
Global Burden of Disease Study including additional 
data sources, advances in modelling strategies, and 
the refinement of a continuous scale (the Socio-
demographic index) to explore levels and trends 
relative to socioeconomic factors between locations. 
This paper uses estimates from the Global Burden of 
Disease Study 2016 to describe patterns of suicide 
mortality globally, regionally, and for 195 countries 
and territories, by age, sex, and Socio-demographic 
index, from 1990 to 2016.
Methods
Overview
The Global Burden of Disease Study 2016 includes 
estimates of mortality owing to 264 causes by location, 
age, and sex between 1990 and 2016 for 195 countries 
and territories. We provide an overview of the methods 
employed by the Global Burden of Disease Study 
2016 with details specific to the estimation of suicide 
mortality. The Global Burden of Disease Study 2016 
used the ICD (international classification of diseases) 
definition of suicide mortality as death caused by 
purposely self-inflicted poisoning or injury (ICD-10 
codes X60-X64.9, X66-X84.9, Y87.0; ICD-9 codes 
E950-E959). For this analysis we present results for 
suicide as an aggregate cause of death. Additional 
detailed results can be explored by using online data 
visualisation tools or downloading a results query tool. 
Our analyses adhere to the Guidelines for Accurate and 
Transparent Health Estimates Reporting (GATHER).24 
The Global Burden of Disease Study 2016 uses de-
identified, aggregated data, therefore a waiver of 
informed consent was reviewed and approved by the 
University of Washington Institutional Review Board 
(application number 46665).
Causes of death data cleaning and formatting
We obtained cause of death data coded as suicide 
from vital registration systems and verbal autopsy 
reports. Vital registration systems collect information 
about births and deaths in a population, and the 
vital registration data used for our analysis contains 
the most detailed cause of death whenever possible 
by using ICD coding systems. We consider vital 
registration data to be of the highest quality, and use 
it whenever possible. 
Verbal autopsy is a method of classifying deaths 
in locations without comprehensive vital registration 
systems. Verbal autopsy uses trained interviewers 
to collect information about signs, symptoms and 
sociodemographic data of the deceased, which are 
then used to infer a cause of death. 
The database developed for the Global Burden of 
Disease Study 2016 contains 15 937 location years 
of vital registration data and 1619 location years of 
data for suicide. The Global Burden of Disease Study 
2016 estimates the period reflecting the initial Global 
Burden of Disease Study, which estimated disease 
burden for 1990 commissioned by the World Bank in 
1993, to the previous calendar year. Our cause of death 
estimation extends back to 1980, but in developing 
countries, data are sparser for these locations before 
1990, so we restricted cause-specific analyses to 1990 
to 2016. Estimates for 2016 are currently available, and 
estimates for 2017 will be available in late 2018. We 
developed a star-rating system to capture the quality 
of data available for each country over the time series 
for Global Burden of Disease estimation. The rating for 
each location is available in supplementary table 1. The 
rating is dependent on availability, completeness, and 
detail of data and the percentage of deaths that are ill-
defined garbage codes or assigned to highly aggregated 
causes. We consider extensive vital registration 
data (ie, vital registration data that is available and 
complete for the Global Burden of Disease estimation 
time series) to be high quality. Additional details on the 
calculation of the rating by using the components can 
be found in the Global Burden of Disease Study 2016 
Causes of Death appendix. We included all data in the 
models to enhance predictive validity for estimates 
in countries without extensive vital registration data. 
We excluded data from countries without extensive 
vital registration coverage from models to avoid 
inflation of uncertainty. We accessed the details of the 
specific data source by location used in the estimation 
process through the Global Burden of Disease data 
tool. Supplementary table 2 shows how many verbal 
autopsy, vital registration, and other sources were 
used for suicide estimation for each location.
The Global Burden of Disease Study 2016 
addressed variation in data quality through a series 
of methods that include data standardisation and 
the redistribution of inappropriately coded deaths or 
“garbage codes” that are not possible causes of death, 
or that are not specific underlying causes of death, 
that have been entered as the underlying cause of 
death on death certificates.23 Undercounting or wrong 
assignment of deaths from suicide is a known problem 
in suicide death estimation, and the level and type of 
wrong assignment differs by location, age, sex, and 
time.22 25 Wrong assignment is corrected for in part by 
reassignment from ICD codes that can include suicide 
deaths, such as undetermined intent injury codes 
(Y10-Y34 in ICD-10; E980-E988 in ICD-9) or exposure 
to unspecified factor (X59 in ICD-10; E887 in ICD-9), 
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or as poorly defined or unknown causes of mortality 
(R99).23 First we determined a set of all possible “target 
causes” for the garbage codes to be redistributed 
onto based on knowledge of pathophysiology or 
certification practices to redistribute these garbage 
codes. Then we used a regression between suicide 
fractions and undetermined intent causes by age 
and sex in each location for each cause of injury to 
estimate the fraction allocated to each target code; the 
same regressions were implemented for homicide and 
unintentional injuries.We redistributed deaths coded 
to undetermined intent causes to suicide, homicide, 
and unintentional injury by using these fractions. 
Supplementary figure 1 shows the variation of direct 
assignment to suicide in women, aged 40 to 44, and 
suicide deaths that were reassigned from other causes 
in six countries for the year 2013.
Estimation
We estimated suicide mortality by using the database 
described above, covariates (see supplementary 
table  3), and the cause of death ensemble model 
(CODEm) framework developed for the Global Burden 
of Disease Study 2016.23 Ensemble modelling is a 
term used to describe the combination of multiple 
independent model frameworks by using assessments 
of their relative predictive power. This method of 
modelling has been shown to estimate more accurate 
measures of uncertainty compared with other 
modelling techniques.23 Using ensemble models 
in the Global Burden of Disease Study 2016 allows 
models for countries with less reliable mortality data 
to borrow strength from adjacent geographies or 
time periods, by weighting the component models, 
to increase the accuracy of the final estimates and 
decrease uncertainty. Models for suicide were age 
limited such that deaths from suicide were restricted to 
a lower limit of age 10, owing to the very low numbers 
of suicide reported among those under the age of 10 
in most populations and difficulty in determining 
intent in children.26 For this study, we developed 
individual CODEm models by sex, and separately for 
each country with or without extensive complete vital 
registration data. There are many model specifications. 
All models are systematically tested by using multiple 
iterations of cross-validation tests to evaluate the out-
of-sample predictive validity of model variants that 
met predetermined requirements for direction and 
significance of regression coefficients. We incorporated 
models that performed best into a weighted, or 
“ensemble” model with the highest weights assigned to 
models with the best out-of-sample prediction error.23
We derived point estimates from the mean of 1000 
draws from the posterior distribution of modelled 
suicide mortality by age, sex, and location; these 1000 
draws for the final ensemble model are from each 
contributing model, with the number of draws being 
contributed proportional to the model’s weight in the 
final ensemble model. We derived 95% uncertainty 
intervals from the 2.5th and 97.5th centiles of these 
1000 draws. We calculated age standardised mortality 
rates by using the time-invariant standard population 
developed for the Global Burden of Disease Study 
2016. Years of life lost incorporate age at the time of 
death and can provide a more integrated view of the 
burden of suicide, particularly where mortality occurs 
at younger ages. We calculated years of life lost as the 
product of the mean age of death by age, sex, year, and 
location and the difference between the age at death 
and the standard life expectancy. In the Global Burden 
of Disease Study 2016, the standard life expectancy 
was 86.6 years, based on the lowest observed risk of 
death in each five year age group, from populations 
of greater than 5 million. Additional details of these 
calculations are available in the online appendix to the 
Global Burden of Disease Study 2016 Causes of Death 
publication.23
We compared rates and levels of suicide mortality 
and years of life lost among locations across age, sex, 
and country development status, for the years 1990 
through 2016 and included 95% uncertainty intervals 
for each point estimate. The Socio-demographic 
index, developed for the Global Burden of Disease 
Study 2016 as a composite measure of development 
status,23 incorporates the geometric mean of total 
fertility rate, income per capita, and mean years of 
education among those aged over 15 to create an 
index for each location. Sex differences in suicide rates 
vary considerably, with a higher female to male ratio 
for countries lower on the development spectrum. We 
explored variation in sex ratios by Socio-demographic 
index level to identify locations where suicide 
mortality sex ratios differ from the expected patterns. 
Temporal change was evaluated from the difference in 
level or rate between time periods. Differences were 
considered statistically significant where the 95% 
uncertainty interval did not include zero (ie, where the 
quantity of interest increased (or decreased) in at least 
95% of the draws).
Patient and public involvement
The investigator did not conduct any interaction or 
intervention with individuals about whom data was 
obtained. Patients and the public were not involved in 
the design, analysis or interpretation of this research 
study.
Results
Global trends
There were 817 000 (95% uncertainty interval 762 000 
to 884 000) deaths globally from suicide in 2016, 
comprising 1.49% (1.39% to 1.61%) of total deaths 
in that year and an all ages rate of 11.1 (10.3 to 12.0) 
deaths per 100 000. The total number of deaths from 
suicide increased globally between 1990 and 2016 
by 6.7% (0.4% to 15.6%), but the age standardised 
mortality rate from suicide decreased by 32.7% (27.2% 
to 36.6%) from 16.6 deaths (15.2 to 17.6) per 100 000 
in 1990 to 11.2 deaths (10.4 to 12.1) per 100 000 in 
2016. In 2016, 34.6 (32.4 to 37.4) million years of life 
lost resulted from suicide. The global age standardised 
rate of years of life lost from suicide was estimated at 
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458.4 (438.5 to 506.1) per 100 000 in 2016 accounting 
for 2.18% (1.9% to 2.2%) of total years of life lost. This 
represented a decrease of 34.2% (28.4% to 38.1%) 
from 1990 when the age standardised years of life lost 
rate was 696.6 (641.4 to 744.2) per 100 000.
Regional trends
Regionally, suicide was in the leading 10 causes 
of death in five of the 21 Global Burden of Disease 
defined regions. Suicide ranked 4th by age 
standardised mortality rate in eastern Europe, 6th 
in high income Asia Pacific, 7th in Australasia, and 
10th in both central Europe and in high income North 
America (supplementary figure 2A). Ranked by age 
standardised years of life lost rate, suicide was the 
leading cause of death in high income Asia Pacific; 3rd 
leading cause in eastern Europe and Australasia; 4th 
in central Europe, western Europe, and high income 
North America; 6th in southern Latin America; and 
8th in central Asia (supplementary fig 2B). Table 1 
shows that the highest regional age standardised 
mortality rate in 2016 was estimated for eastern 
Europe (27.5 deaths per 100 000, 95% uncertainty 
interval 10.1 to 37.2), followed by high income 
Asia Pacific (18.7, 15.6 to 21.7), and southern sub-
Saharan Africa (16.3, 14.3 to 19.3). Table 2 shows 
that a similar pattern was observed for regional age 
standardised years of life lost rates with the highest 
age standardised years of life lost rate estimated for 
eastern Europe (1200.3 years of life lost per 100 000, 
95% uncertainty interval 869.2 to 1635.9), followed 
by high income Asia Pacific (742.0, 614.6 to 855.6) 
and southern sub-Saharan Africa (664.1, 579.6 
to 809.8). The age standardised mortality rate for 
suicide decreased across most Global Burden of 
Disease regions between 1990 and 2016, with only 
non-significant increases observed for the regions 
of central Latin America (14.6%, 95% uncertainty 
interval −5.9% to 31.3%), high income Asia Pacific 
(10.1%, −23.5% to 30.0%), western sub-Saharan 
Africa (4.3%, −10.4% to 20.7%), and eastern Europe 
(1.4%, −24.2% to 34.3%). 
Figure 1 shows that there were periods of increases 
and declines in the age standardised mortality rate 
from suicide for men in eastern Europe in particular. 
The age standardised mortality rate from suicide for 
men in eastern Europe was similar at the beginning 
and end of the study period (27.1 deaths per 100 000, 
95% uncertainty interval 23.8 to 34.1 in 1990; 27.5, 
20.1 to 37.2 in 2016) and rose as high as 42.8 deaths 
per 100 000 (95% uncertainty interval 33.7 to 50.2) 
during this period.
National trends
Considerable variability emerged beneath these 
regional patterns. High rates of suicide mortality in a 
few countries influenced regional averages in Global 
Burden of Disease regions, particularly South Korea in 
high income Asia Pacific, Indonesia in South East Asia, 
and Lesotho and Zimbabwe in Southern sub-Saharan 
Africa (supplementary table 1). Figure 2 shows that in 
2016, for countries with populations greater than 1 
million, age standardised mortality rates from suicide 
were highest in Lesotho (39.0 deaths per 100 000, 
95% uncertainty interval 25.5 to 55.7), Lithuania 
(31.0, 25.6 to 36.2), Russia (30.6, 20.6 to 43.6), and 
Zimbabwe (27.8, 21.1 to 37.3). Figure 3 shows that 
in 2016, for countries with populations greater than 
1 million, rates of age standardised years of life lost 
were highest in Lesotho (1413.2 years per 100 000, 
95% uncertainty interval 944.9 to 2065.9), Russia 
(1349.5, 889.7 to 1922.4), Lithuania (1317.8, 1065.1 
Table 1 | Total number of deaths, age standardised mortality rate (ASMR) per 100 000 from suicide in 2016, and total percent change in ASMR from 
suicide 1990 to 2016, for all regions 
Region No of deaths (95% UI)
ASMR (95% UI) Percent change  
(95% UI)
Female to male 
ASMR ratioMen Women Total
East Asia 138 000 (129 000 to 154 000) 10.9 (9.8 to 12.8) 6.6 (6.1 to 7.1) 8.7 (8.2 to 9.7) −63.0 (−65.7 to −55.8) 0.6
South East Asia 42 000 (39 000 to 50 000) 10.3 (9.1 to 12.5) 3.6 (3.3 to 4.0) 6.9 (6.3 to 8.0) −34.0 (−41.6 to −17.3) 0.3
Oceania 1000 (1000 to 2000) 20.5 (14.5 to 28.5) 7.5 (4.8 to 11.6) 14.1 (10.1 to 17.4) −13.0 (−27.7 to 8.2) 0.4
Central Asia 11 000 (9000 to 13 000) 21.1 (16.2 to 25.2) 4.8 (4.2 to 5.5) 12.5 (10.2 to 14.5) −3.3 (−16.5 to 10.9) 0.2
Central Europe 19 000 (16 000 to 21 000) 22.6 (17.9 to 25.9) 4.2 (3.9 to 4.5) 13.0 (10.8 to 14.5) −23.3 (−32.7 to −14.5) 0.2
Eastern Europe 68 000 (50 000 to 94 000) 50.0 (34.8 to 71.1) 8.3 (5.6 to 12.2) 27.5 (20.1 to 37.2) 1.4 (−24.1 to 34.4) 0.2
High income Asia Pacific 46 000 (38 000 to 53 000) 26.9 (20.1 to 32.6) 11.0 (9.3 to 12.9) 18.7 (15.6 to 21.7) 10.1 (−23.5 to 30.0) 0.4
Australasia 3000 (3000 to 4000) 16.4 (13.0 to 19.2) 5.0 (4.5 to 5.5) 10.6 (9.0 to 12.0) −19.9 (−31.7 to −8.3) 0.3
Western Europe 53 000 (47 000 to 65 000) 15.2 (13.4 to 20.8) 4.3 (4.1 to 4.6) 9.6 (8.7 to 12.4) −31.4 (−38.0 to −20.0) 0.3
Southern Latin America 8000 (7000 to 9000) 19.6 (16.0 to 24.0) 4.1 (3.6 to 4.7) 11.5 (9.7 to 13.6) −15.0 (−27.3 to −1.1) 0.2
High income North America 51 000 (43 000 to 57 000) 20.0 (16.2 to 23) 5.8 (5.5 to 6.0) 12.7 (10.8 to 14.1) −2.3 (−14.4 to 3.1) 0.3
Caribbean 4000 (4000 to 5000) 15.3 (12.9 to 17.6) 4.0 (3.3 to 4.7) 9.4 (8.3 to 10.6) −24.5 (−32.9 to −15.5) 0.3
Andean Latin America 3000 (2000 to 3000) 7.4 (5.6 to 8.8) 2.9 (2.4 to 3.3) 5.1 (4.2 to 5.8) −6.4 (−23.0 to 12.7) 0.4
Central Latin America 16 000 (13 000 to 19 000) 11.0 (8.5 to 13.4) 2.1 (1.9 to 2.3) 6.4 (5.2 to 7.6) 14.6 (−5.9 to 31.3) 0.2
Tropical Latin America 14 000 (12 000 to 18 000) 10.8 (8.8 to 14.0) 2.3 (2.0 to 2.6) 6.4 (5.3 to 7.9) −11.6 (−22.4 to 4.4) 0.2
North Africa and Middle East 26 000 (23 000 to 31 000) 6.8 (5.9 to 8.4) 2.6 (2.4 to 3.0) 4.8 (4.2 to 5.6) −2.8 (−15.7 to 14.3) 0.4
South Asia 252 000 (214 000 to 273 000) 18.2 (12.7 to 20.2) 12.6 (11.2 to 13.9) 15.4 (12.9 to 16.6) −17.5 (−25.8 to −3.2) 0.7
Central sub-Saharan Africa 7000 (5000 to 9000) 16.6 (11.6 to 22.5) 6.0 (5.0 to 7.1) 10.9 (8.5 to 14.0) −2.3 (−21.4 to 17.4) 0.4
Eastern sub-Saharan Africa 24 000 (21 000 to 28 000) 18.7 (15.8 to 22.1) 7.0 (5.9 to 8.2) 12.5 (11.1 to 14.1) −15.3 (−26.5 to 2.3) 0.4
Southern sub-Saharan Africa 11 000 (10 000 to 13 000) 26.1 (21.9 to 31.6) 7.8 (6.7 to 8.9) 16.3 (14.3 to 19.3) −10.8 (−25.0 to 19.1) 0.3
Western sub-Saharan Africa 19 000 (16 000 to 25 000) 12.6 (10.2 to 17.1) 6.7 (4.8 to 8.9) 9.6 (7.9 to 12.3) 4.3 (−10.4 to 20.7) 0.5
UI=uncertainty interval
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to 1547.5), Kazakhstan (1119.9, 858.9 to 1462.7), 
and Mongolia (998.1, 744.3 to 1230.5). 
Figure 2 shows that age standardised mortality rates 
for suicide were lowest in Lebanon (2.4 deaths per 
100 000, 95% uncertainty intervals 1.6 to 3.5), Syria 
(2.5, 2.0 to 3.0), Palestine (2.7, 2.1 to 3.6), Kuwait 
(2.7, 1.7 to 3.8), and Jamaica (2.9, 2.2 to 3.7). Figure 
3 shows that rates of age standardised years of life lost 
rates were lowest in the same countries.
Between 1990 and 2016, noticeable decreases 
in age standardised mortality rates from suicide 
were estimated for 63 of the 195 countries and 
territories in the Global Burden of Disease Study 2016 
(supplementary table 1). Figure 4 shows that the largest 
statistically significant decreases occurred in China 
(64.1%, 95% uncertainty interval 57.1% to 66.7%), 
Denmark (60.0%, 37.6% to 68.3%), the Philippines 
(58.1%, 10.4% to 69.8%), Singapore (50.6%, 31.0% 
to 62.9%), and Switzerland (50.3%, 27.9% to 63.5%), 
as well as in the smaller countries of the Maldives 
(59.1%, 36.3% to 72.0%) and Seychelles (56.1%, 
26.6% to 65.9%). Deaths from suicide in China and 
India—as the most populous countries—together 
constituted 44.2% of global suicide deaths in 2016. 
However, the large decrease in the age standardised 
mortality rate from suicide in China over the past 
27 years was not matched in India where the age 
standardised mortality rate decreased by 15.2% (95% 
uncertainty interval 0.3% to 23.7%). Globally, the age 
standardised mortality rate from suicide increased in 
some locations, with the largest statistically significant 
increases estimated for Zimbabwe (96.2%, 95% 
uncertainty interval 30.7% to 268.4%), Jamaica 
(70.9%, 21.0% to 128.2%), Paraguay (70.4%, 23.2. to 
117.1), Zambia (61.6%, 5.23% to 128.7%), and Belize 
(52.2%, 8.8% to 100.7%).
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Fig 1 | Age standardised mortality rate from suicide, by Global Burden of Disease super 
region, for women and men, 1990 to 2016
Table 2 | Total number of years of life lost (YLL) and age standardised rate (ASR) of YLL per 100 000 from suicide in 2016, and total percent change in 
ASR of YLL from suicide 1990 to 2016, for all regions
Region No of YLL (95% UI)
ASR of YLL (95% UI) Female to male 
ASR of YLL ratioMen Women Total
East Asia 4 665 000 (4 418 000 to 5 330 000) 353.7 (323.4 to 430.8) 223.8 (208.7 to 241.1) 289.6 (274.4 to 330.3) 0.6
South East Asia 1 864 000 (1 690 000 to 2 231 000) 420.1 (369.5 to 516.8) 134.9 (121.7 to 152.1) 276.1 (250.6 to 329.2) 0.3
Oceania 78 000 (54 000 to 99 000) 1013.2 (693.5 to 1409.7) 344.8 (206.5 to 547.7) 684.6 (472.7 to 858.2) 0.3
Central Asia 528 000 (418 000 to 617 000) 946.1 (704.9 to 1133.6) 224.0 (196.9 to 253.9) 575.1 (457.5 to 671.3) 0.2
Central Europe 671 000 (550 000 to 746 000) 882.2 (687.8 to 994.6) 155.8 (145.1 to 168.4) 517.0 (420.4 to 574.9) 0.2
Eastern Europe 2 769 000 (2 000 000 to 3 767 000) 2118.2 (1455.2 to 3016.8) 346.4 (225.9 to 517.2) 1200.3 (869.2 to 1635.9) 0.2
High income Asia Pacific 1 480 000 (1 228 000 to 1 708 000) 1034.7 (774.0 to 1248.3) 447.5 (377.6 to 533.3) 742.0 (614.6 to 855.6) 0.4
Australasia 141 000 (119 000 to 159 000) 729.8 (593.9 to 856.9) 225.5 (202.9 to 251.5) 477.2 (409.0 to 539.6) 0.3
Western Europe 1 785 000 (1 617 000 to 2 346 000) 602.6 (532.4 to 859.4) 167.5 (158.5 to 178.1) 384.1 (347.2 to 514.0) 0.3
Southern Latin America 340 000 (277 000 to 392 000) 838.8 (645.7 to 998.1) 188.1 (162.9 to 217.6) 510.2 (414.4 to 589.8) 0.2
High income North America 2 062 000 (1 745 000 to 2 270 000) 856.4 (696.9 to 973.2) 257.6 (245.3 to 268.7) 556.4 (473.7 to 613.3) 0.3
Caribbean 174 000 (153 000 to 199 000) 598.1 (515.9 to 707.4) 160.9 (128.4 to 199.7) 375.9 (329.7 to 429.7) 0.3
Andean Latin America 140 000 (115 000 to 159 000) 324.8 (243.3 to 385.6) 136.6 (116.6 to 157.4) 230.0 (190.4 to 262.4) 0.4
Central Latin America 813 000 (657 000 to 988 000) 503.8 (382.8 to 630.8) 106.2 (98.4 to 117.2) 302.4 (245.3 to 365.1) 0.2
Tropical Latin America 649 000 (543 000 to 803 000) 464.7 (373.9 to 603.1) 103.0 (90.4 to 117.1) 280.9 (235.1 to 348.2) 0.2
North Africa and Middle East 1 281 000 (1 141 000 to 1 532 000) 308.6 (266.7 to 382.3) 117.8 (104.4 to 132.3) 216.0 (192.0 to 257.1) 0.4
South Asia 12 636 000 (10 923 000 to 13 692 000) 782.9 (562.1 to 868.9) 626.6 (556.1 to 690.5) 704.8 (605.1 to 764.8) 0.8
Central sub-Saharan Africa 275 000 (208 000 to 374 000) 532.4 (370.4 to 747.5) 180.2 (150.9 to 220.7) 351.3 (269.0 to 462.0) 0.3
Eastern sub-Saharan Africa 969 000 (848 000 to 1 111 000) 555.7 (464.5 to 665.8) 203.8 (172.4 to 236.9) 373.5 (330.5 to 425.2) 0.4
Southern sub-Saharan Africa 510000 (442000 to 628000) 1056.5 (896.2 to 1341.8) 296.1 (250.8 to 344.3) 664.1 (579.6 to 809.8) 0.3
Western sub-Saharan Africa 783 000 (644 000 to 1 020 000) 397.1 (316.9 to 543.2) 182.2 (133.9 to 240.8) 288.9 (238.1 to 375.7) 0.5
UI=uncertainty interval
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Sex and age trends
Globally, the age standardised mortality rate was 
higher for men (15.6 deaths per 100 000, 95% 
uncertainty interval 13.7 to 17.2) than for women (7.0, 
6.5 to 7.4), however, the rate of decrease from 1990 
to 2016 was lower for men (23.8%, 95% uncertainty 
interval 15.6% to 32.7%) than for women (49.0%, 
42.6% to 54.6%). This was reflected in the female to 
male ratio which was 0.73 in 1990 and 0.46 in 2016. 
In 2016, for countries with a population greater than 
1 million, the age standardised mortality rates from 
suicide were highest for men in Lithuania (56.6 deaths 
per 100 000, 95% uncertainty interval 44.4 to 67.7), 
Russia (55.3, 34.9 to 85.0), and Kazakhstan (44.2, 
32.5 to 59.6). The age standardised mortality rate for 
suicide were highest for women in Lesotho (35.4, 16.8 
to 54.7), Uganda (18.7, 12.7 to 25.5), Liberia (17.0, 
12.5 to 21.5), and South Korea (15.5, 10.0 to 22.7) 
(supplementary table 1). 
The age standardised mortality rates from suicide in 
2016 were lowest for men in Lebanon (3.4 deaths per 
100 000, 95% uncertainty interval 2.0 to 5.6), Kuwait 
(3.8, 2.1 to 5.7), Pakistan (3.9, 2.9 to 5.2), Syria (4.0, 
3.1 to 5.1), and Palestine (4.1, 3.0 to 5.7). The age 
standardised mortality rate from suicide were lowest 
for women in Syria (1.0, 0.8 to 1.2), Oman (1.1, 0.9 
to 1.3), Jamaica (1.1, 0.8 to 1.5), and Greece (1.2, 1.0 
to 1.4).
Although age standardised mortality rates were 
lower for women than for men across all regions, 
strong regional variation in relative rates by sex existed 
in 2016. Table 1 shows that the lowest ratios of suicide 
mortality rates for women compared with those for men 
occurred in the regions of eastern (0.17) and central 
(0.18) Europe, and across central (0.19), southern 
(0.21), and tropical (0.21) Latin America. This ratio 
was closest to parity in east (0.60) and south (0.69) 
Asia. At the national level, rates of suicide mortality for 
women were lower than those for men in all countries 
except for Liberia (1.08) (supplementary table 1). 
Relative ratios of female to male age standardised 
mortality rates were also comparatively high for many 
countries across Africa (Morocco 0.95, Nigeria 0.88, 
and Lesotho 0.88), as well as for many countries in 
south Asia (Pakistan 0.96, Bangladesh 0.73, and India 
0.69).
Figure 5 shows that, for men and women and across 
all regions, rates of suicide mortality were highest for 
the oldest age groups. However, suicide did not rank in 
the leading 10 causes of death for those aged 70 and 
over (supplementary fig 3A). At the same time, regional 
variation in the overall age distribution of mortality 
rates from suicide was notable – with comparatively 
high rates for younger adults in several regions. In the 
10 to 24 age group, suicide was ranked in the leading 
five causes of mortality in all Global Burden of Disease 
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Fig 2 | Age standardised mortality rate from suicide for men and women combined, 2016
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regions except for central, eastern, western, and 
southern sub-Saharan Africa (supplementary fig 3B). 
Figure 5 shows that a bimodality in the distribution 
of age specific mortality rates was particularly evident 
for women in south Asia and for men in central 
Europe, eastern Europe, and central Asia and in north 
Africa and Middle East. Across the time series, global 
mortality rates from suicide were greater, although 
not significantly so, for women than for men only 
among those in the 15 to 19 age group (supplementary 
table 4), although the gap in this age group has also 
decreased over time (supplementary fig 4). In 2016 
mortality rates from suicide for men exceeded those 
for women in all other age groups by as much as 2.98 
times.
For both sexes combined, higher levels of suicide 
deaths occurred before age 30 in south Asia (46.0% 
of all suicide deaths), Latin America and Caribbean 
(38.7%), and North Africa and the Middle East (38.6%) 
(supplementary fig 5). These higher proportions of 
suicide deaths among those under 30 reflects the age 
structure of these populations as age specific mortality 
rates in the under 30 populations are relatively lower 
compared with rates at older ages, except for women in 
south Asia. Deaths from suicide for those younger than 
30 comprised less than 30% of total suicide deaths in 
other Global Burden of Disease super regions. One fifth 
of suicide deaths occurred among those aged 60 or 
over in the Global Burden of Disease super regions of 
high income (20.8%), and South East Asia, east Asia, 
and Oceania (24.8%).
Socio-demographic index and differences by sex
Globally, ratios of suicide deaths were skewed strongly 
towards lower rates for women, but there was a 
large variation between locations related to Socio-
demographic index level. Figure 6 shows that the 
ratio of age standardised mortality rates for women 
compared with men were highest in countries with 
a low Socio-demographic index, however, not all 
countries followed this trend (eg, China has a Socio-
demographic index 0.73 and a female to male ratio 
of 0.61). For the 23 countries with a female to male 
ratio of 0.50 or greater, there was no clear association 
between Socio-demographic index and this ratio. A 
small number of countries were estimated to have 
both a relatively low Socio-demographic index and a 
low female to male ratio of age standardised mortality 
rate from suicide including Afghanistan, Mozambique, 
Malawi, and Central African Republic.
Discussion
Suicide continues to be an important cause of 
preventable mortality worldwide, resulting in an 
estimated 817 000 deaths in 2016. When ranking 
leading causes by age standardised mortality rate, this 
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Fig 3 | Age standardised rate of years of life lost (YLL) from suicide for men and women combined, 2016
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Fig 5 | Age specific mortality rate from suicide by Global Burden of Disease super region and five year age groups for women and men, 2016
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study found that suicide deaths were in the leading 
10 causes of death across eastern Europe, central 
Europe, high income Asia Pacific, Australasia, and 
high income North America. When ranked by age 
standardised years of life lost rates, suicide was the 
leading cause of death in high income Asia Pacific 
and was among the top 10 leading causes in eastern 
Europe, central Europe, western Europe, central Asia, 
Australasia, southern Latin America, and high income 
North America. Suicide continues to be an important 
cause of mortality in most countries worldwide, but 
it is promising that both the global age standardised 
mortality rate and years of life lost rate from suicide 
have decreased by a third between 1990 and 2016. 
Globally, the decline in the age standardised mortality 
rate from suicide (32.7%) we noted is similar to that 
estimated by the Global Burden of Disease Study 2016 
for all cause mortality (30.6%).23 Whether the decline 
in suicide mortality is due to suicide prevention 
activities, or whether it reflects general improvements 
to population health, warrants further research.
The decline in the age standardised mortality rate 
has not been universal. There is considerable variation 
in suicide mortality and rates of change between 
the sexes, across age groups, and between regions. 
Consistent with previous research, men had higher 
rates of suicide at all time points, for all age groups 
except for among those aged 15 to 19.27-29 In this age 
group women had consistently higher rates of suicide 
mortality; however, this gap narrowed between 1990 
and 2016 to almost parity in 2016. A greater decline 
in the global suicide mortality rate was estimated for 
women (49.0%) than men (23.8%), and if this trend 
continues, differences in suicide mortality by sex will 
continue to widen. The association between lower 
levels of Socio-demographic index and higher female 
to male ratios warrants further research to understand 
if this pattern reflects a higher level of behaviour 
related to suicide among women in these countries, 
or a relatively higher level of lethality of the means 
used by women in countries with lower development 
contexts.18 28 30 Regional variation is also apparent. 
For example, post-communist privatisation and the 
Russian economic crisis of 1998 were followed by 
increases in suicide mortality in eastern Europe, in 
contrast to a general pattern of decreasing mortality 
rates overall.31 32 Much of the global estimated decline 
is owing to the large decrease in suicide mortality in 
China during the study period, and the lower but still 
important decrease in India. The changes observed 
in China have been attributed to economic growth, 
urbanisation, improved standards of living, and better 
access to medical care in rural areas.33 34 Page and 
colleagues report that the share of pesticide poisoning 
suicides, the most common means of suicide in China, 
decreased from 55% to 49% between 2006 and 
2013.35 Further research to understand if changes to 
availability or lethality of pesticides has contributed 
to this decline could suggest a scalable public health 
intervention for other similar contexts.
Taken as a whole, these patterns reflect a complex 
interplay of factors, specific to regions and nations, 
including sociodemographic, sociocultural, and 
religious factors6 36; levels of economic development, 
unemployment and economic events 7 9; distribution 
of risk factors, such as exposure to violence or use of 
alcohol and drugs 8 10; choices of and access to means 
of suicide 12 37; and patterns of mental illness and as 
well as culturally specific relations with suicide.15 21 
Moreover, although the decrease in suicide mortality 
has been substantial during the period 1990 to 2016, 
if current trends continue, only 3% of 118 countries 
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Fig 6 | Ratio of female to male age standardised mortality rate for suicide by Socio-demographic index level by location, 2016. Location codes are 
described in full in supplementary table 5
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will attain the Sustainable Development Goals target 
to reduce suicide mortality by one third between 2015 
and 2030.38
Strengths and weaknesses of this study
In estimating suicide mortality rates by using methods 
that are comparable over time and between countries 
for the period 1990 to 2016, this study provides 
comprehensive estimates of suicide mortality and years 
of life lost by age, sex, region, and country. In addition, 
this study improves on country-level estimates 
through data standardisation and redistribution of 
insufficiently detailed or implausible cause of death 
codes, which is particularly relevant for suicide 
deaths. This study is limited by the gaps in data, 
especially among low and middle income countries, 
and variations in data quality in the Global Burden 
of Disease Study. The Global Burden of Disease Study 
2016 employs data standardisation and evaluations of 
data quality in a sophisticated modelling framework 
that borrows strength across space and time to 
address some of these issues.23 Because of the social, 
cultural, religious, and sometimes legal ramifications 
of a death by suicide, there are additional concerns 
with respect to under-reporting of suicide. A recent 
systematic review concluded that in general, suicide 
deaths are under-reported, although more research 
on the reliability of suicide data, especially in low 
and middle income countries, is needed.25 Moreover, 
under-reporting and misclassification of suicide 
could be affected by sociocultural factors,39 resulting 
in differential misclassification. Owing to this, 
lower rates in countries with religious and cultural 
sanctions against suicide should be interpreted with 
caution. Although the Global Burden of Disease Study 
2016 method to reclassify garbage codes adjusts for 
some of this misclassification,23 this could still be a 
conservative estimate of the suicide mortality rate if 
suicide deaths are wrongly assigned to other plausible 
causes, such as unintentional injuries, when deaths are 
recorded.22 25 This paper has not reported the burden 
of suicide attributable to risk factors such as mental 
disorders, drug and alcohol use, or violence  10  14; 
further research quantifying the contribution of these 
and other risk factors to suicide mortality would be 
useful in informing interventions to prevent suicide.
Conclusion and policy implications
Although there has been progress on reducing 
suicide mortality in recent decades, suicide remains 
an important preventable contributor to the global 
burden of disease across all regions. National, 
regional, sex, and age related variations yield insight 
which can inform suicide prevention initiatives, 
adding to existing effective suicide prevention 
interventions.17 Sociocultural and economic factors 
must also be considered, as temporal and global 
patterns underscore their likely contribution to suicide 
mortality.7 9 A continued focus on strengthening data 
on suicide deaths is needed, including accurately 
capturing suicide deaths in low and middle income 
countries,25 as well as data on means of suicide.11  40 
Similarly, more evidence on effective suicide 
prevention interventions is needed, particularly in 
low and middle income countries. The evaluation of 
national and regional suicide prevention strategies, 
such as Preventing Suicide in England,41 the National 
Suicide Prevention Plan 2015-2020 for Guyana,42 and 
the Fiji National Mental Health and Suicide Prevention 
Policy will provide evidence to support the public 
health community to strengthen effective efforts and to 
redirect activities that are not impactful.5 17 43 However, 
care must be taken to not apply strategies that work to 
dissimilar contexts. Research must continue to build 
the evidence base for effective interventions that are 
sensitive to regional and national contexts to address 
this continuing public health concern.
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